ScreenerHero

NKGN NKGen Biotech, Inc.

Partial data
NAS · US · Healthcare · Biotechnology · nkgenbiotech.com
0.0020USD0.00%Mkt Cap: 7.84M $P/E: —

NKGen Biotech, Inc., a clinical-stage biotechnology company, develops and commercializes cell therapies for neurodegenerative and oncological diseases based on activated natural killer (NK) cells in the United States. Th…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.47BUSDP/E 29.3
MRNA
Moderna, Inc.
$78.65BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.14BUSDP/E 18.3
ARGX
argenx SE
$51.48BUSDP/E 31.2
ARGX
argenx SE
$48.23BUSDP/E 31.4
UCB
UCB SA
$41.82BUSDP/E 17.8
RVMD
Revolution Medicines, Inc.
$40.32BUSD
ONC
BeOne Medicines AG
$39.83BUSDP/E 62.6
RPRX
Royalty Pharma plc
$32.48BUSDP/E 29.9
ALNY
Alnylam Pharmaceuticals, Inc.
$30.04BUSDP/E 37.9
ROIV
Roivant Sciences Ltd.
$24.71BUSD
BNTX
BioNTech SE
$23.13BUSD
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
GMAB
Genmab A/S
$22.17BUSDP/E 28.4
INSM
Insmed Incorporated
$21.94BUSD
GMAB
Genmab A/S
$21.10BUSDP/E 29.1
ASND
Ascendis Pharma A/S
$14.65BUSDP/E 17.1
EXEL
Exelixis, Inc.
$14.62BUSDP/E 18.6
JAZZ
Jazz Pharmaceuticals plc
$14.44BUSDP/E 15.2
SMMT
Summit Therapeutics Inc.
$13.70BUSD

Key Statistics

Company
Market Cap7.84M USD
Enterprise Value39.75M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-23.55M USD
Revenue/Share—
Last Price0.0020 USD
Fiscal Year EndDec 2024
MR QuarterMar 2025
Employees26
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-1.75
EV/Revenue—
P/S—
P/B-0.06
EPS (TTM)-1.33
EPS (Forward)—
52W Range
0.00100% of range0.3300
52W High0.3300 USD
52W Low0.0010 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE—
ROA-93.33%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-21.95M USD
CapEx (TTM)48.00K USD
FCF Margin—
FCF Yield-267.32%
Net Debt38.19M USD
Net Debt/EBITDA-1.68
Balance Sheet
Debt/Equity-0.34
Current Ratio0.05
Quick Ratio0.00
Book Value/Sh-0.98 USD
Cash/Share0.00 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.130.60M
Float67.59M
Insiders58.97%
Institutions2.11%
Short Interest
Short Ratio0.4d
Short % Float5.53%
Short % Out.3.35%
Shares Short1.51M
Short (prev mo.)561.27K
Technical
SMA 500.0161 (-87.5%)
SMA 2000.0556 (-96.4%)
Beta0.72
S&P 52W Chg15.96%
Avg Vol (30d)5.68K
Avg Vol (10d)6.08K
Technical Indicators
RSI (14)25.9
MACD-0.0062
MACD Signal-0.0077
MACD Hist.+0.0015
BB Upper0.0098 USD
BB Middle0.0040 USD
BB Lower-0.0019 USD
BB Width294.73%
ATR (14)0.0039 USD
Vol Ratio (20d)0.00x